MA55512A - Sel de phosphoramidates de triphosphate de nucléotides en tant que composés anticancéreux - Google Patents

Sel de phosphoramidates de triphosphate de nucléotides en tant que composés anticancéreux

Info

Publication number
MA55512A
MA55512A MA055512A MA55512A MA55512A MA 55512 A MA55512 A MA 55512A MA 055512 A MA055512 A MA 055512A MA 55512 A MA55512 A MA 55512A MA 55512 A MA55512 A MA 55512A
Authority
MA
Morocco
Prior art keywords
phosphoramidates
salt
nucleotide triphosphate
anticancer compounds
anticancer
Prior art date
Application number
MA055512A
Other languages
English (en)
Inventor
Ciano Samuele Di
Hugh Griffith
Fabrizio Pertusati
Michaela Serpi
Magdalena Slusarczyk
Original Assignee
NuCana plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NuCana plc filed Critical NuCana plc
Publication of MA55512A publication Critical patent/MA55512A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MA055512A 2019-04-01 2020-04-01 Sel de phosphoramidates de triphosphate de nucléotides en tant que composés anticancéreux MA55512A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1904544.2A GB201904544D0 (en) 2019-04-01 2019-04-01 Anticancer compounds

Publications (1)

Publication Number Publication Date
MA55512A true MA55512A (fr) 2022-02-09

Family

ID=66443062

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055512A MA55512A (fr) 2019-04-01 2020-04-01 Sel de phosphoramidates de triphosphate de nucléotides en tant que composés anticancéreux

Country Status (16)

Country Link
US (1) US20220024963A1 (fr)
EP (1) EP3947408B1 (fr)
JP (1) JP2022528679A (fr)
KR (1) KR20210146960A (fr)
CN (1) CN113661169A (fr)
AU (1) AU2020251748A1 (fr)
BR (1) BR112021019282A2 (fr)
CA (1) CA3133894A1 (fr)
CL (1) CL2021002536A1 (fr)
EA (1) EA202192660A1 (fr)
GB (1) GB201904544D0 (fr)
IL (1) IL286815A (fr)
MA (1) MA55512A (fr)
MX (1) MX2021012038A (fr)
SG (1) SG11202110344YA (fr)
WO (1) WO2020201751A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0317009D0 (en) 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds
GB0505781D0 (en) 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
DK3031812T3 (en) 2011-03-01 2018-09-17 NuCana plc CHEMICAL COMPOUNDS
IL291927A (en) 2014-11-28 2022-06-01 NuCana plc Oligonucleotides containing modified nucleosides
JP6735751B2 (ja) * 2014-12-15 2020-08-05 エモリー ユニバーシティー Ｂ型肝炎ウイルスの治療のためのホスホルアミデート

Also Published As

Publication number Publication date
IL286815A (en) 2021-10-31
US20220024963A1 (en) 2022-01-27
CN113661169A (zh) 2021-11-16
KR20210146960A (ko) 2021-12-06
AU2020251748A1 (en) 2021-10-14
EP3947408B1 (fr) 2023-06-07
SG11202110344YA (en) 2021-10-28
EP3947408A1 (fr) 2022-02-09
WO2020201751A1 (fr) 2020-10-08
CA3133894A1 (fr) 2020-10-08
JP2022528679A (ja) 2022-06-15
EA202192660A1 (ru) 2022-01-14
GB201904544D0 (en) 2019-05-15
BR112021019282A2 (pt) 2022-02-01
MX2021012038A (es) 2021-11-03
CL2021002536A1 (es) 2022-06-17

Similar Documents

Publication Publication Date Title
FR24C1009I1 (fr) Composés utilisés comme inhibiteurs de kinase
MA47131A (fr) Composés benzyl-amide phosphodiamide antiviraux
CO2017008403A2 (es) Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos
MA42990A (fr) Composés utiles en tant qu'immunomodulateurs
BR112018010118A2 (pt) inibidores de cxcr2
MA49752A (fr) Procédés de préparation de composés de pyrrolidine
MA43169A (fr) Composés hétérocycliques utilisés en tant qu'inhibiteurs de pi3k-gamma
MA53150A (fr) Composés de benzimidazole en tant qu'inhibiteurs de c-kit
MA40301B1 (fr) Composés indolecarboxamides utiles comme inhibiteurs de kinase
EA201692537A1 (ru) Замещенные нуклеозиды, нуклеотиды и их аналоги
DK3464249T3 (da) Substituerede carbonnukleosidderivater, der er anvendelige som anticancermidler
MA41272A (fr) 5-fluoro-4-imino-3-(alkyle/alkyle substitué)-1-(arylsulfonyl)-3,4-dihydropyrimidin-2(1h)-one en tant que traitement des semences
MA52948A (fr) Composés
MA51669A (fr) Composés
MA40302A1 (fr) Dérivés de carbazole
DK3464309T3 (da) Phosphoramidatnukleosidderivater som anticancermidler
MA53003A (fr) Composés
BR112016024936A2 (pt) moduladores de gpr40 à base de pirrolidina para tratamento de doenças como diabetes
MA46878A (fr) Composés de benzodiazolium en tant qu'inhibiteurs d'enac
MA44020A (fr) Composés antitumoraux
MA41424A (fr) Composés vegfa/ang2
MA49623A (fr) Composés chimiques
MA53479A (fr) Composés hétérocycliques en tant q'inibiteurs de vanin
MA52946A (fr) Composés
MA51221A (fr) Composés de pyrazolopyridinone